to assess metabolic, anthropometric and cardiovascular risk profile of a cohort undergoing stable nevirapine therapy associated with TDF+FTC (TVD), AZT+3TC (CBV) or ABC+3TC (KVX)
Different metabolic and anthropometric characteristics of TVD, CBV or KVX associated with nevirapine. Results from the “NEVIRAPINE COMPANION” cross-sectional cohort / Guaraldi, Giovanni; Adorni, F.; Sconiamilio, C.; Zona, S.; Squillace, N.; Orlando, G.; Stentarelli, C; Esposito, Roberto. - In: ANTIVIRAL THERAPY. - ISSN 1359-6535. - STAMPA. - 13 (4):(2008), pp. A41 (n. P-27 )-A42. (Intervento presentato al convegno 10th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV tenutosi a London, UK nel 6-8 November 2008).
Different metabolic and anthropometric characteristics of TVD, CBV or KVX associated with nevirapine. Results from the “NEVIRAPINE COMPANION” cross-sectional cohort
GUARALDI, Giovanni;ESPOSITO, Roberto
2008
Abstract
to assess metabolic, anthropometric and cardiovascular risk profile of a cohort undergoing stable nevirapine therapy associated with TDF+FTC (TVD), AZT+3TC (CBV) or ABC+3TC (KVX)
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
